Macrophage Plasticity in Experimental Atherosclerosis

As in human disease, macrophages (MØ) are central players in the development and progression of experimental atherosclerosis. In this study we have evaluated the phenotype of MØ associated with progression of atherosclerosis in the apolipoprotein E (ApoE) knockout (KO) mouse model. We found that bone marrow-derived MØ submitted to M1 and M2 polarization specifically expressed arginase (Arg) II and Arg I, respectively. This distinct arginase expression was used to evaluate the frequency and distribution of M1 and M2 MØ in cross-sections of atherosclerotic plaques of ApoE KO mice. Early lesions were infiltrated by Arg I+ (M2) MØ. This type of MØ favored the proliferation of smooth muscle cells, in vitro. Arg II+ (M1) MØ appeared and prevailed in lesions of aged ApoE KO mice and lesion progression was correlated with the dominance of M1 over the M2 MØ phenotype. In order to address whether the M2->M1 switch could be due to a phenotypic switch of the infiltrated cells, we performed in vitro repolarization experiments. We found that fully polarized MØ retained their plasticity since they could revert their phenotype. The analysis of the distribution of Arg I- and Arg II-expressing MØ also argued against a recent recruitment of M1 MØ in the lesion. The combined data therefore suggest that the M2->M1 switch observed in vivo is due to a conversion of cells already present in the lesion. Our study suggests that interventional tools able to revert the MØ infiltrate towards the M2 phenotype may exert an atheroprotective action.

[1]  S. Haulon,et al.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. , 2007, Cell metabolism.

[2]  Judith E. Allen,et al.  Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. , 2003, Immunology letters.

[3]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[4]  M. Modolell,et al.  Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines , 1995, European journal of immunology.

[5]  G. Kaplan,et al.  Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens , 2008, Nature Immunology.

[6]  John Parkinson,et al.  IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype , 2002, BMC Immunology.

[7]  Mark L. Benson,et al.  Isolation of vascular smooth muscle cells from a single murine aorta. , 2001, Methods in cell science : an official journal of the Society for In Vitro Biology.

[8]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[9]  B Staels,et al.  PPARgamma and atherosclerosis. , 2005, Current medical research and opinion.

[10]  J. Suttles,et al.  Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences1 , 2005, The Journal of Immunology.

[11]  D. Umetsu,et al.  Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity , 2003, Nature Medicine.

[12]  H. Ljunggren,et al.  CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis , 2004, The Journal of Experimental Medicine.

[13]  D. Klatzmann,et al.  The Proatherogenic Role of T Cells Requires Cell Division and Is Dependent on the Stage of the Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[14]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[15]  T. Irimura,et al.  The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL‐4/IL‐13 signaling , 2006, Journal of leukocyte biology.

[16]  P. Heeringa,et al.  Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR−/− Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[17]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[18]  M. Munder,et al.  Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. , 1998, Journal of immunology.

[19]  F. Sutterwala,et al.  Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type I , 1998, The Journal of experimental medicine.

[20]  Guoyao Wu,et al.  Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. , 2001, American journal of physiology. Endocrinology and metabolism.

[21]  J. Suttles,et al.  Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.

[22]  S. Kaveri,et al.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. , 1998, The Journal of clinical investigation.

[23]  C. Glass,et al.  Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[24]  F. Tacke,et al.  Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.

[25]  D. Dormont,et al.  Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.

[26]  Michael Ginsberg,et al.  Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Caldwell,et al.  Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. , 1997, The American journal of physiology.

[28]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[29]  L. Ignarro,et al.  Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. , 1995, Biochemical and biophysical research communications.

[30]  P. Loke,et al.  Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection1 , 2007, The Journal of Immunology.

[31]  O. Levillain,et al.  Localization and differential expression of arginase II in the kidney of male and female mice , 2005, Pflügers Archiv.

[32]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.